|
|
|
Volumn 42, Issue 1071, 2000, Pages 11-12
|
|
Aggrenox: A combination of antiplatelet drugs for stroke prevention
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE;
ADENOSINE;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DIPYRIDAMOLE;
PHOSPHODIESTERASE INHIBITOR;
PROSTAGLANDIN SYNTHASE INHIBITOR;
THROMBOXANE A2;
TICLOPIDINE;
UNCLASSIFIED DRUG;
WARFARIN;
CEREBROVASCULAR ACCIDENT;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
HUMAN;
MORTALITY;
SHORT SURVEY;
STROKE;
TRANSIENT ISCHEMIC ATTACK;
ASPIRIN;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
DIPYRIDAMOLE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COMBINATIONS;
DRUG THERAPY, COMBINATION;
FEES, PHARMACEUTICAL;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
|
|
EID: 0034615260
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|